SPS Webinar: Nonclinical Allergenicity of Biologics & PK Modeling/Simulation as Translational Tool

The Safety Pharmacology Society is pleased to invite you to a webinar on Nonclinical Allergenicity of Biologics and PK Modeling and Simulation as Translational Tool on April 9, at 11:00 am ET.


Title: Nonclinical Allergenicity of Biologics 

Presenter: Kenneth Hastings, DrPH, DABT, Fellow ATS
Hastings Toxicology Consulting LLC

Summary: Over the last decade, an increasing number of biologics have entered drug development. Biotechnologies using human sequences can induce anti-drug antibodies or activate an immune reaction with consequences on nonclinical drug safety testing studies. While nonclinical allergenicity of biologics can cause important functional and also structural changes, the clinical relevance of drug allergenicity observed with human sequences delivered to animals is often limited. A broad perspective on allergenicity of biologics will be presented with a review of scientific considerations related to this important topic in drug development.

Title:  Modeling and Simulation as a Preclinical to Clinical Translational Tool 

Presenter: Martin Beliveau, MSc, PhD
Director, Pharmacometrics
Pharsight Consulting Services™
A division of Certara™
Summary: Often, the insight gained from preclinical studies gets lost when transiting to human clinical development. Modeling and simulation provides a simple framework with tools that can provide insight into doses or regimens in possible target populations, such as pediatric or elderly patients, based on current mechanistic understanding of efficacy, safety and pharmacokinetics in animals. This framework can be used for various molecule types (small and large), for stages of drug development or indications, potentially accelerating critical decision making. 

Moderator: Simon Authier, DVM, MBA, PhD, DSP
Director Safety Pharmacology, CiToxLAB

We look forward to your participation. Register today!

SPS Headquarters

Recent Stories
Late-breaking abstract deadline closes tonight!

Invitation to the SPS Virtual Meeting: Registration is Open!

There is Still Time! Submit Your Abstract to the SPS Virtual Meeting